Dissimilarity-based approaches to compound acquisition.

Curr Opin Chem Biol 2008 Jun 28;12(3):366-71. Epub 2008 May 28.

Eli Lilly and Company, 1 Corporate Center, Indianapolis, IN 46285, USA.

The concept of molecular diversity has been integrated in drug discovery efforts for many years. Applications of molecular diversity have been used to identify compounds for screening and to select compounds to augment proprietary collections. These early efforts were crude and suffered from a number of faults, but their evolution has, over the years, led to an improvement in the computational procedures used to identify new commercial compounds for acquisition. Although not much has recently been written about modern methods for augmenting compound collections, this activity is still a very relevant and important task to those involved with the development of compound collections. This review focuses on the process and software used to identify compounds deemed worthy of acquisition.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cbpa.2008.03.010DOI Listing
June 2008

Publication Analysis

Top Keywords

molecular diversity
8
identify compounds
8
compound collections
8
improvement computational
4
acquisition written
4
computational procedures
4
procedures identify
4
compounds acquisition
4
identify commercial
4
commercial compounds
4
led improvement
4
efforts crude
4
early efforts
4
collections early
4
crude suffered
4
suffered number
4
years led
4
evolution years
4
faults evolution
4
written modern
4

Similar Publications